Nitric oxide differentially affects constitutive cytochrome p450 isoforms in rat liver

Journal of Pharmacology and Experimental Therapeutics

Volumn 280, Issue 3, 1997, Pages 1463-1470

  Khatsenko, Oleg ^a   Kikkawa, Yutaka ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; APOPROTEIN; CYTOCHROME P450 ISOENZYME; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; ETHOXYRESORUFIN; ETHOXYRESORUFIN DEETHYLASE; HEME; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PENTOXYRESORUFIN; RESORUFIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEALKYLATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; HYDROXYLATION; IMMUNOBLOTTING; LIVER MICROSOME; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CYTOCHROME P-450 ENZYME SYSTEM; DOWN-REGULATION; HEME; ISOENZYMES; LIVER; MALE; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 0030989836     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. BERRY, E. A. AND TRUMPOWER, B. L.: Simultaneous determination of hemes a, b, and c from pyridine hemochrome spectra. Anal. Biochem. 161: 1-15, 1987.
2. BISSEL, M. AND HAMMAKER, L.: Cytochrome P450 heme and the regulation of δ-aminolevulinic acid synthetase in the liver. Arch. Biochem. Biophys. 176: 103-112, 1976.
3. BRADFORD, M. M.: A rapid and sensitive method for the quatitation of microgram qualities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-253, 1976.
4. BURKE, M. D. AND MAYER, R. T.: Differential effects of phenobarbitone and 3-methylcholan-threne induction on the hepatic microsomal metabolism and cytochrome P450 binding of phenoxazone and a homologous series of its n-alkyl esters (alkoxyresorufins). Chem. Biol. Interact. 45: 243-258, 1983.
5. CARLSON, T. J. AND BILLINGS, R. E.: Role of nitric oxide in the cytokine-mediated regulation of cytochrome P450. Mol. Pharmacol. 49: 796-801, 1996.
6. CHAMULITRAT, W., JORDAN, S. J., MASON, R. P., LITTON, A. L., WILSON, J. G., WOOD, E. R., WOLBERG, G. AND MOLINA Y VEDIA.: Targets of nitric oxide in a mouse model of liver inflammation by Corynebacterium parvum. Arch. Biochem. Biophys. 316: 30-37, 1995.
7. CORBETT, A., TILTON, R. G. AND CHANG, K.: Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 41: 552-556, 1992.
8. DRAPIER, J. C., HIRLING, H., WIETZERBIN, J., KALDY, P. AND KUHN, L. C.: Biosynthesis of nitric oxide activates iron regulatory factor in macrophages. EMBO J. 12: 3643-3649, 1993.
9. G-L-nitroarginine. Biochemistry 32: 8512-8517, 1993.
10. GRAIG, P. I., MEHTA, I., MURRAY, M., MCDONALD, D., ASTROM, A., VAN DER MEIDE, P. H. AND FARRELL, G. C.: Interferon down regulates the male-specific cytochrome P450IIIA2 in rat liver. Mol. Pharmacol. 38: 313-318, 1990.
11. GRUETTER, C. A., BARRY, B. K., GRUETTER, D. Y. AND IGNARRO, L. J.: Coronary arterial relaxation and guanylate cyclase activation by cigarette smoke, N'-nitrosonornicotine and nitric oxide. J. Pharm. Exp. Ther. 214: 9-15, 1980.
12. HENRY, Y., DUCROCQ, C., DRAPIER, J-C., SERVENT, D., PELLAT, C. AND GUISSANI, A.: NITRIC OXIDE, A BIOLOGICAL EFFECTOR. EUR. BIOPHYS. J. 20: 1-15, 1991.
13. HEWETT, J. A. AND ROTH, R. A.: Hepatic and extrahepatic pathology of bacterial lipopolysaccarides. Pharm. Rev. 45: 381-411, 1993.
14. KERWIN, J. F., LANCASTER, J. R. AND FELDMAN, P. L.: Nitric oxide: A new paradigm for second messengers. J. Med. Chem. 38: 4343-4362, 1995.
15. KHATSENKO, O. G., GULYAEVA, L. F., MISHIN, V. M. AND LYAKHOVICH, V. V.: Evaluation of catalytic activity of cytochrome P450 multiple forms in liver microsomes of Wistar rats by androstenedione metabolism. Biochemistry (USSR) 55: 308-315, 1991.
16. KHATSENKO, O. G., GROSS, S. S., MITCHELL, J. A., RIFKIND, A. R. AND VANE, J. R.: Inhibition of cytochrome P450 activity by nitric oxide in vitro and during endotoxin shock in vivo. Br. J. Pharmacol 107: P196, 1992.
17. KHATSENKO, O. G., GROSS, S. S., RIFKIND, A. R. AND VANE, J. R.: Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants. Proc. Natl. Acad. Sci. U.S.A. 90: 11147-11151, 1993.
18. KIM, Y. M., BERGONIA, H. A., MÜLLER, C., PITT, B. R., WATKINS, W. D. AND LANCASTER, J. R.: Loss and degradation of enzyme-bound heme induced by cellular nitric oxide synthesis. J. Biol. Chem. 270: 5710-5713, 1995.
19. KIM, Y-M., BERGONIA, H. A., MULLER, C., PITT, B. R., WATKINS, W. D. AND LANCASTER, J. R.: Nitric oxide and intracellular heme. Adv. Pharmacol. 34: 277-291, 1995.
20. LAEMMLI, U. K.: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
21. MIYATA, M., NAGATA, K., SHIMADA, M., YAMAZOE, Y. AND KATO, R.: Structure of a gene and cDNA of a major constitutive form of testosterone 6β-hydroxylase (P450/6βA) encoding CYP3A2: Comparison of the cDNA with P450 PCN2. Arch. Biochem. Biophys. 314: 351-359, 1994.
22. MORGAN, E. T.: Suppression of constitutive cytochrome P450 gene expression in livers of rats undergoing an acute phase response to endotoxin. Mol. Pharmacol. 36: 699-707, 1989.
23. MORGAN, E. T.: Down-regulation of multiple cytochrome P450 gene products by inflammatory mediators in vivo. Biochem. Pharmacol. 45: 415-419, 1993.
24. O'KEEFFE, D. H., EBEL, R. E. AND PETERSON, J. A.: Studies of the oxygen binding site of cytochrome P450. J. Biol. Chem. 253: 3509-3516, 1978.
25. OMIECINSKI, C. J., REDLICH, C. A. AND COSTA, P.: Induction and developmental expression of cytochrome P4501A1 messenger RNA in rat and human tissues: Detection by the polymerase chain reaction. Cancer Res. 50: 4315-4321, 1990.
26. OMURA, T. AND SATO, R.: The carbon monooxide-binding pigment of liver microsomes. II Solubilisation, purification and properties. J. Biol. Chem. 239: 2379-2385, 1964.
27. OSAWA, Y., DAVILA, J. C., NAKATSUKA, M., MEYER, C. A. AND DARBYSHIRE, J. F.: Inhibition of cytochromes P450 by reactive intermediates. Drug Metab. Rev. 27: 61-72, 1995.
28. OYEKAN, A. O.: The suppression by lipopolysaccharide of cytochrome P450-dependent renal vasodilation in the rat is mediated by nitric oxide. Eur. J. Pharmacol. 277: 123-132, 1995.
29. PADMANABAN, G., VENKATESWAR, V. AND RANGARAJAN, P. N.: Heme as a multifunctional regulator. Trends Biochem. Sci. 14: 492-496, 1989.
30. PORTER, T. D. AND COON, M. J.: Cytochrome P450: multiplicity of isoforms, substrates and catalytic and regulatory mechanisms. J. Biol. Chem. 266: 13469-13472, 1991.
31. RENTON, K. W. AND MANNERING, C. J.: Depression of hepatic drug-metabolizing systems with administered Interferon inducing agents. Biochem. Biophys. Res. Commun. 73: 343-348, 1976.
32. RENTON, K. W.: Relationships between the enzymes of detoxication and host defense mechanism. In: Biological Basis of Detoxication, ed. by J. Caldwell and W. B. Jacoby, pp. 307-324 USA, New York, Academic Press, 1983.
33. RIBEIRO, V. AND LECHNER, M. C.: Cloning and characterization of a novel CYP3A1 allelic variant: Analysis of CYP3A1 and CYP3A2 sex-hormone-dependent expression reveals that the CYP3A2 gene is regulated by testosterone. Arch. Biochem. Biophys. 293: 147-152, 1992.
34. SAKAI, H., OKAMOTO, T. AND KIKKAWA, Y.: Suppression of drug metabolism by the interferon inducer, polyriboinosic acid: Polyribocitidylic acid. J. Pharmacol. Exp. Ther. 263: 381-386, 1992.
35. SALVEMINI, D., MISKO, T. P., MASFERRER, J. L., SEIBERT, K., CURRIE, M. G. AND NEEDLEMAN, P.: Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. U.S.A. 90: 7240-7244, 1993.
36. SINCLAIR, P. R., BEMENT, W. J., HAUGEN, S. A., SINCLAIR, J. F. AND GUZELIAN, P. S.: Induction of cytochrome P450 and 5-aminolevulinate synthase activities in cultured rat hepatocytes. Cancer Res. 50: 5219-5224, 1990.
37. SONAWANE, B. R. AND YAFFE S. J.: Effects of endotoxin upon rat hepatic microsomal drug metabolism in vivo and in vitro. Xenobiotica 12: 303-313, 1982.
38. SOUCEK, P. AND GUT, I.: Cytochromes P450 in rats: Structures, functions, properties and relevant human forms. Xenobiotica 22: 83-103, 1992.
39. SRIVASTAVA, G., HANSEN, A. J., BAWDEN, M. J. AND MAY, B. K.: Hemin administration to rats reduces levels of hepatic mRNAs for phenobarbitone-inducible enzymes. Mol. Pharmacol. 38: 486-493, 1990.
40. STADLER, J., TROCKFELD, J., SCHAMALIX, W. A., BRILL, T., SIEWERT, J. R., GREIM, H. AND DOEHMER, J.: Inhibition of cytochromes P4501A by nitric oxide. Proc. Natl. Acad. Sci. U.S.A. 91: 3559-3563, 1994.
41. STARK, M. E. AND SZURSZEWSKI, J. H.: Role of niric oxide in gastrointestinal and hepatic function and disease. Gastroenterology 103: 1928-1948, 1992.
42. TRACEY, W. R., TSE, J. AND CARTER, G.: Lipopolysaccaride-induced changes in plasma nitrite and nitrate concentrations in rat and mice: Pharmacological evaluation of nitric oxide synthase inhibitors. J. Pharm. Exp. Ther. 272: 1011-1015, 1995.
43. WAGNER, D. A., YOUNG, V. R. AND TANNENBAUM, S. R.: Mammalian nitrate biosynthesis: Incorporation of 15NH3 into nitrate is enhanced by endotoxin treatment. Proc. Natl. Acad. Sci. U.S.A. 80: 4518-4522, 1983.
44. WAXMAN, D. J. AND WALSH, C.: Regioselectivity and stereospecificity of androgen hydroxylations catalyzed by cytochrome P450 isozymes purified from phenobarbital-induced rat liver. J. Biol. Chem. 258: 11937-11947, 1983.
45. WEISS, G., GOOSSEN, B., DOPPLER, W., FUCHS, D., PANTOPOULOS, K., WERNER-FELMAYER, G., WACHTER, H. AND HENTZE, M. W.: Translational regulation via iron-responsive elements by the nitric oxide/NO synthase pathway. EMBO J. 12: 3651-3657, 1993.
46. WINK, D. A., OSAWA, Y., DARBYSHIRE, J. F., JONES, C. R., ESHENAUER, S. C. AND NIMS, R. W.: Inhibition of cytochrome P450 by nitric oxide and nitric-oxide releasing agent. Arch. Biochem. Biophys. 300: 115-123, 1993.
47. WRIGHT, K. AND MORGAN, E. T.: Transcriptional and posttranscriptional suppression of P450IIC11 and P450IIC12 by inflammation. FEBS Lett. 271: 59-61, 1990.
48. YOSHIOKA, H., MOROHASHI, K., SOGAWA, K., MIYATA, T., KAWAJIRI, K., HIROSE, T., INAYAMA, S., FUJII-KURIYAMA, Y. AND OMURA, T.: Structural analysis and specific expression of microsomal cytochrome P450(M1) mRNA in male rat livers. J. Biol. Chem. 262: 1706-1711, 1987.